Over 100 years ago Western New York gave modern cancer research to the world through what would become the Roswell Park Cancer Institute. Today our region continues to lead the way in medical and scientific research. As a Member of the House Cancer Caucus, Brian has been a steadfast supporter for cancer research, both for local researchers and for the nation’s cancer program generally. Brian has led efforts among his colleagues to increase funding for cancer research and is engaged with the cancer community on innovations that will alleviate suffering due to cancer and ultimately find a cure. Brian has introduced H.R. 1801, the Cancer Drug Coverage Parity Act, which would require health insurance companies to provide the same coverage for new, promising orally-administered anti-cancer medication as it does for traditional intravenous chemotherapy.
More on Cancer Research
Today, thousands of advocates from across the country gather in Washington, D.C. to rally in support of medical research funding. The crowd in the nation’s capital will include more than 50 researchers from Roswell Park Cancer Institute.
Congressman Brian Higgins (NY-26) joined Roswell Park Cancer Institute (RPCI) President & CEO Dr. Donald Trump and American Cancer Society Cancer Action Network (ACS CAN) Federal Government Relations Director Hillary Clarke to outline the local impact of federal investments in cancer research and the devastating impact cuts, including possible sequestration, would have on both the economy and the effort to improve cancer outcomes.
Congressman Brian Higgins (NY-26) announced the University at Buffalo (UB) has been awarded a $59,031 federal grant from the National Cancer Institute (NCI).
Congressman Brian Higgins (NY-26) announced that researchers at Roswell Park Cancer Institute have been awarded a $276,234 grant from the National Cancer Institute (NCI) to conduct research on gender disparity in bladder cancer.